Frontlight ResearchEarly access
Trial site
Medizinische Hochschule Hannover (MHH)
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Heart failure2 trials
- ANCA-associated vasculitis1 trial
- Cerebral palsy1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Dystonia1 trial
- Hearing loss1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lupus (SLE)1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Alentis Therapeutics AG1 trial
- Bayer1 trial
- Boston Scientific Corporation1 trial
- Cochlear1 trial
- CRISPR Therapeutics1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ANCA-associated vasculitis1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Dystonia1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Lupus (SLE)1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026